LGND - Ligand Pharmaceuticals Incorporated News

GainersToday.com, Tracking Stock Market Picks

Enter Symbol:

Home
- Upgrades
- Downgrades

Gainers

Losers

Rankings
- Accuracy
- Gains
- Trade Avg
- Trade
- Trade Year

Sectors

Directory

Blog

Tools
- Mobile
- Gadgets


Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas

of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

( Total: 13 Current Stock Recommendations )

Ligand Pharmaceuticals Incorporated (13)

Hold 23%

Buy 77%

Related companies

China Biologic ... (4)

Buy 100%

BioSpecifics ... (5)

Buy 100%

PROLOR Biotech, Inc. (5)

Buy 100%

Opko Health Inc (2)

Buy 100%

Flamel Technologies ... (8)

Buy 100%

Aeterna Zentaris, ... (12)

Buy 100%

Lannett Co Inc (4)

Buy 100%

Anika Therapeutics ... (4)

Buy 100%

Emergent ... (6)

Buy 100%

Insys Therapeutics ... (4)

Buy 100%

Filter by Gains: Show:

Rating:
Buy LGND

76.82 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $140 by ROTH Capital
Wednesday, Sep 30, 2015 8:25 AM ET

Rating:
Hold LGND

52.22 %

Ligand Pharmaceuticals Incorporated (LGND) upgraded to Hold with price target $93 by Cantor Fitzgerald
Friday, Jun 19, 2015 10:25 AM ET

Rating:
Hold LGND

19.96 %

Ligand Pharmaceuticals Incorporated (LGND) downgraded to Hold with price target $94 by Deutsche Bank
Monday, Jun 15, 2015 12:25 PM ET

Rating:
Buy LGND

19.96 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $94 by Deutsche Bank
Wednesday, Apr 1, 2015 2:25 PM ET

Rating:
Buy LGND

42.95 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $102 by CRT Capital
Tuesday, Mar 3, 2015 9:25 AM ET

Rating:
Buy LGND

70.43 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $74 by Deutsche Bank
Tuesday, Dec 2, 2014 1:25 PM ET

Rating:
Buy LGND

76.82 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $116 by ROTH Capital
Wednesday, Nov 19, 2014 10:25 AM ET

Rating:
Buy LGND

692.01 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $91 by Summer Street Research
Monday, Feb 24, 2014 10:25 AM ET

Rating:
Buy LGND

53.27 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $96 by MLV & Co
Thursday, Feb 13, 2014 8:25 AM ET

Rating:
Buy LGND

53.27 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $82 by MLV & Co
Monday, Feb 10, 2014 8:25 AM ET

Rating:
Buy LGND

692.01 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $78 by Summer Street Research
Monday, Jan 27, 2014 9:25 AM ET

Rating:
Buy LGND

692.01 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $64 by Summer Street Research
Friday, Aug 2, 2013 11:25 AM ET

Rating:
Sell LGND

52.22 %

Ligand Pharmaceuticals Incorporated (LGND) downgraded to Sell with price target $37 by Cantor Fitzgerald
Friday, Aug 2, 2013 8:25 AM ET

Rating:
Hold LGND

Ligand Pharmaceuticals Incorporated (LGND) rated Hold with price target $26 by Cantor Fitzgerald
Monday, Mar 18, 2013 8:25 AM ET

Rating:
Hold LGND

9.87 %

Ligand Pharmaceuticals Incorporated (LGND) downgraded to Hold with price target $23 by Cantor Fitzgerald
Friday, Jan 4, 2013 8:25 AM ET

Subscribe to our Newsletter.

Your Recent Stocks

Symbol	Last	Change
LGND	86.03	-8.72 %

| | |

| | | | | | |